help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 4, 2003, doi:10.1164/rccm.200305-702OC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200305-702OCv1
169/4/525    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutierrez, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutierrez, G.
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 525-533, (2004)
© 2004 American Thoracic Society

A Mathematical Model of Tissue–Blood Carbon Dioxide Exchange during Hypoxia

Guillermo Gutierrez

Pulmonary and Critical Care Medicine Division, George Washington University, Washington, DC

Correspondence and requests for reprints should be addressed to Guillermo Gutierrez, M.D., Ph.D., Director, Pulmonary and Critical Care Medicine Division, George Washington University, 2150 Pennsylvania Avenue, N.W., Suite 5-404, Washington, DC 20037. E-mail: ggutierrez{at}mfa.gwu.edu


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 
A two-compartment mass transport model of tissue CO2 exchange is developed to examine the relative contributions of blood flow and cellular hypoxia (dysoxia) to increases in tissue and venous blood CO2 concentration. The model assumes perfectly mixed homogeneous conditions, steady-state equilibrium, and CO2 production occurring exclusively at the tissues. The behavior of the model is compared with published data derived from an isolated dog hindlimb preparation subjected to either reductions in blood flow (ischemic hypoxia) or decreases in arterial PO2 (hypoxic hypoxia). The results of the model corroborate the experimental finding of greater venous and tissue CO2 concentrations with ischemic hypoxia than with hypoxic hypoxia. The model also predicts increases in tissue CO2 concentration under conditions of adequate O2 supply if CO2 transfer from tissue to blood becomes impaired. Consequently, from a theoretical perspective, it appears that increases in the tissue or venous blood CO2 concentration are neither sensitive nor specific markers of tissue dysoxia. The results of the model support the notion that changes in tissue and venous blood CO2 concentration during dysoxia reflect primarily alterations in vascular perfusion and not scarcity in cellular energy supply.

Key Words: CO2 production • oxygen delivery • oxygen consumption • tissue oxygenation • venous PCO2

Dysoxia, defined as a deficit in aerobic ATP production in relationship to cellular energy requirements (1), occurs when cellular energy flux is limited either by decreases in O2 supply or by impaired mitochondrial aerobic capacity (2). The tissue CO2 concentration ([CO2]t) increases during dysoxia as hydrogen ions generated by anaerobic sources of energy are buffered by bicarbonate (3). Consequently, measures of CO2 accumulation in tissues and in venous blood have been proposed as clinical markers of dysoxia (4). Techniques to monitor increases in peripheral CO2 include gastric mucosal PCO2, sublingual capnography, and the arteriovenous PCO2 difference (av{Delta}PCO2) (57). Increases in gastric mucosa PCO2 have been associated with increases in mortality (8), and therapy guided by this measurement has been shown to improve patient survival (9).

The physiologic significance of increases in [CO2]t is controversial because CO2 can be generated by aerobic and anaerobic biochemical processes. During tissue dysoxia, a rise in [CO2]t may result from lactic acid buffering by bicarbonate ("anaerobic CO2") or from flow stagnation as CO2 produced during pyruvate oxidation ("aerobic CO2") accumulates in poorly perfused tissues (10).

Vallet and colleagues (11) explored this question by measuring venous PCO2 in isolated dog hindlimb preparations subjected to comparable decreases in O2 delivery (O2) produced by two different mechanisms. In one group, blood flow was progressively decreased (ischemic hypoxia [IH]), whereas in the other group, arterial PO2 was lowered at constant perfusion flow (hypoxic hypoxia [HH]). Both groups experienced similar declines in O2 and O2, implying similar degrees of tissue dysoxia (12), but the av{Delta}PCO2 remained constant in the HH group and increased almost threefold in the IH group. Vallet and colleagues concluded that flow, not tissue dysoxia, is the major determinant of av{Delta}PCO2. Neviere and colleagues (13) also noted lower intestinal mucosal PCO2 in pigs during HH when compared with IH, a finding corroborated by Dubin and colleagues (14) in sheep intestine. These data support the hypothesis that increases in venous PCO2 and [CO2]t are primarily a function of changes in regional blood flow, independent of the degree of tissue dysoxia. This article describes the development of a mass transport model of tissue CO2 exchange to examine the validity of this hypothesis.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 
Model Development
CO2 transport from tissue to blood involves several complex, time-dependent, mass-transport processes. CO2 diffuses out of cells into the interstitial fluid where it is found dissolved, bound to bicarbonate as carbonic acid, and bound to proteins as carbamate. CO2 in blood is also distributed among these moieties both in plasma and inside the red blood cells (15). Convective transport by the circulation carries CO2 to the lungs for excretion into the atmosphere.

The mass transport model shown in Figure 1 is proposed as a first approximation to these processes. The model consists of two compartments: a tissue compartment and a vascular compartment. The following assumptions are made in the formulation of the model: (1) Blood is a homogeneous mixture of erythrocytes and plasma, (2) perfectly mixed compartments, (3) constant physical properties, (4) CO2 production (CO2) occurs exclusively in the tissue compartment, (5) constant blood flow, (6) all transport processes reach equilibrium condition during the passage of blood through the microvasculature, and (7) negligible diffusive postcapillary losses of CO2 from venules to arterioles.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. The tissue CO2 exchange model consists of two perfectly mixed compartments: a tissue and a vascular compartment. Changes in tissue and vascular CO2 concentrations, [CO2]t, and [CO2]v depend on CO2 production, CO2, arterial CO2 concentration, [CO2]a, the diffusion term Kv, and tissue blood flow ().

 
The rate of change of [CO2] in the tissue compartment is a function of CO2 and of the rate of CO2 transfer between the tissue and vascular compartments. This relationship may be described as follows:

where [CO2] represents the total CO2 concentration (dissolved and bound) and the subscripts t and v denote the tissue and vascular compartments, respectively. Kv is the mass transfer coefficient for CO2.

For the vascular compartment, the rate of change of [CO2]v depends on blood flow per unit volume of tissue () on the arteriovenous content difference and on the rate of CO2 transfer between the two compartments.


As shown in the Appendix, the steady-state solution of this system of equations is as follows:


These equations were tested under conditions of decreasing oxygen delivery in which O2 and O2 changed according to the nonlinear paradigm described by Cain (16) for resting animal preparations. A detailed development of the equations governing the input functions of the model is shown in the Appendix.

The equations of the model were programmed using Microsoft Excel. Model-predicted changes in the av{Delta}PCO2 were compared with the experimental results published by Vallet and colleagues (11) in isolated dog hindlimb exposed to decreases in DO2 produced by either ischemia or hypoxic hypoxia.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 
Model Input Parameters
The input parameters used in the model simulations are shown in Table 1 . Most of the values in that table conform to the experimental conditions reported by Vallet and colleagues (11). These include arterial PCO2 of 34 mm Hg, arterial O2 saturation of 0.98 (corresponding to the reported arterial PO2 of 100 Torr), and limb respiratory quotient of 0.6. Because the hemoglobin concentration and arterial pH were not reported by Vallet and colleagues (11), values for dog blood of hemoglobin concentration of 150 g · L-1 and pH of 7.35 were assumed. Initial O2 and O2 values of 10 ml · kg-1 · min-1 and 4.8 ml · kg-1 · min-1, respectively, along with a critical O2 extraction ratio (ERO2) of 0.65 were obtained from Vallet and colleagues (11). These values resulted in a (O2)critical of 6.9 ml · kg-1 · min-1, a number equal to that reported by Vallet et al (11) for HH.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Model input parameters: initial values

 
Model Input Functions
Input functions for the model consist of decreases in or arterial PO2 and the associated changes in O2, O2, and CO2. Figure 2 shows O2 as a function of for IH and as a function of arterial PO2 for HH. Decreases in and arterial PO2 replicate the conditions experienced by the experimental preparation of Vallet and colleagues (11). Decreases in during IH are linearly related to O2, whereas changes in PO2 during HH conform to the shape of the oxyhemoglobin dissociation curve. As shown in Figure 3 , the parameters of Table 1 result in input functions that closely approximate the experimental O2O2 and O2–ERO2 curves. The discrete points in these graphs correspond to the experimental data of Vallet and colleagues (11) for the IH and HH experiments.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 2. Model input functions used to simulate decreases in tissue blood flow (ischemic hypoxia [IH]) and in arterial PO2 (hypoxic hypoxia [HH]), conforming to the conditions of the study by Vallet and colleagues (11).

 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Changes in O2 consumption and O2 extraction ratio as functions of the rate of O2 delivery. The result of the model is shown as a solid line in each graph, along with the experimental data from Vallet and colleagues (11) for IH (open circle) and HH (closed circle). Input parameters for the model are those of Figure 2 and Table 1. ERO2 = O2 extraction ratio.

 
The model defines O2 as the sum of CO2 produced by aerobic and by anaerobic energy processes. Aerobic CO2 depends solely on O2 and the tissue's respiratory quotient. Anaerobic CO2 is a function of the parameter FCO2, a user-defined variable that relates anaerobic CO2 to the maximal rate of anaerobic ATP production (see Appendix). Alterations in FCO2 produce different rates of anaerobic CO2 when O2 is less than (O2)crit.

The effect of FCO2 on CO2 can be best appreciated from Figure 4 (top) showing aerobic and anaerobic CO2 as functions of O2 for values of FCO2 ranging from 0 to 0.20. Aerobic CO2 remains constant until O2 is less than O2crit, when it declines in concert with decreases in O2. Anaerobic CO2 appears below O2crit, with greater FCO2 values resulting in steeper O2-anaerobic CO2 curves. Figure 4 (bottom) shows the sum of the aerobic and anaerobic CO2 components. Depending on the value of FCO2, total CO2 below O2crit may be greater or less than initial CO2. An FCO2 of 0.10 results in constant CO2 for all values of O2. A value of FCO2 of 0.03 was chosen for these simulations because it resulted in a O2CO2 relationship that approximates closely that reported by Vallet and colleagues (11). This is shown in Figure 5 .



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. (Top) Aerobic (dashed line) and anaerobic CO2 production (solid lines) as functions of O2 for values of FCO2 from 0 to 0.20. (Bottom) Total CO2 production (aerobic plus anaerobic CO2) as a function of O2. Total CO2 remains constant with decreases in O2 that is more than or equal to O2crit. Below O2crit, CO2 may decrease or increase, depending on the value of FCO2. An FCO2 value of 0.10 corresponds to constant CO2 throughout the range of O2.

 


View larger version (13K):
[in this window]
[in a new window]
 
Figure 5. Predicted tissue CO2 production as a function of O2. The result of the model is shown as a solid line. Also shown are the experimental data from Vallet and colleagues (11) for IH (open circle) and HH (closed circle).

 
Comparison of the Model Predictions to Experimental Data
Figure 6 shows predicted changes in av{Delta}PCO2 for identical decreases in O2 for the IH and HH conditions. The experimental data of Vallet and colleagues (11) are shown as discrete points. Although both groups are subject to exactly equal degrees of tissue dysoxia, the model predicts a substantial increase in av{Delta}PCO2 during IH, whereas this parameter remains constant during HH.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 6. Predicted changes in arteriovenous PCO2 difference (av{Delta}PCO2) as a function of DO2. The model predictions for IH and HH are shown as solid lines. Also shown are the experimental data from Vallet and colleagues (11) for IH (open circle) and HH (closed circle).

 
Model Sensitivity to FCO2
The sensitivity of the predicted [CO2]v and [CO2]t to FCO2 was tested by running multiple simulations with the initial conditions of Table 1 and a range of FCO2 values. Figure 7 shows changes in venous blood and tissue [CO2] for IH and HH as FCO2 varies from 0.01 to 1.00. The latter corresponds to maximal anaerobic CO2 production, the condition in which each mole of anaerobic ATP generates a mole of CO2. At any given FCO2, decreases in O2 result in different [CO2] for IH and HH. In the case of IH, the model predicts progressively larger increases in [CO2]v and [CO2]t with increasing FCO2. Conversely, in the case of HH, [CO2]v and [CO2]t increase only when FCO2 is more than 0.30, although to a much lesser degree than during IH.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 7. Changes in blood and tissue [CO2] for IH and HH at constant Kv = 0.05 and FCO2 values ranging from 0.01 to 1.00.

 
Model Sensitivity to Kv
The tissue CO2 diffusion coefficient Kv is another user-defined variable. It determines the rate of CO2 transfer from the tissues to the vascular space. According to Equation 5B (Appendix), the parameter Kv has no effect on venous [CO2], and whatever value is selected for Kv will not alter predicted changes in av{Delta}PCO2. A value of 0.05 was chosen in these simulations as a reasonable estimate for Kv. This choice was based on the sensitivity analysis shown in Figure 8 for Kv values ranging from 0.10 to 0.001, with other input parameters being those shown in Table 1.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 8. Sensitivity of the model to changes in the diffusion term Kv with FCO2 = 0.03. Changes in tissue and venous blood CO2 content are shown as functions of with values of Kv from 0.1 to 0.001. The predictions for IH are shown as solid lines and those for HH as dashed lines. Lower Kv values result in higher tissue CO2 concentrations but have no effect on venous PCO2.

 
Conversely, Kv is an important determinant of tissue [CO2]. As shown in Figure 8, lower Kv values (corresponding to decreases in tissue CO2 diffusivity) result in increased initial [CO2]t for the IH and HH conditions, even though at that point the tissues are not dysoxic. In other words, according to the model, it may be possible to detect increases in tissue PCO2 resulting solely from decreases in CO2 diffusivity, irrespective of the degree of tissue dysoxia. As O2 decreases, [CO2]t diverges for the two conditions tested, with HH (dashed line) being consistently lower than corresponding IH values (solid line).


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 
Many clinical and experimental studies support the notion that increases in venous PCO2 are temporally related to the development of tissue dysoxia. Large increases in mixed venous blood PCO2 have been measured during cardiopulmonary resuscitation in humans, a phenomenon associated with moderate increases in blood lactic acid concentration (17). Increases in mixed venous blood PCO2 under these extreme conditions of global ischemia have been attributed to buffering of anaerobically generated lactic acid by endogenous bicarbonate. Experimental animals undergoing cardiopulmonary resuscitation also show substantial increases in blood lactate concentration, mixed venous blood PCO2, and the venoarterial PCO2 difference (18).

The hypothesis that a rise in tissue PCO2 could serve as a marker of tissue dysoxia was advanced by Grum and colleagues (19) who measured increases in tissue PCO2 in the isolated dog intestine made dysoxic. Other experimental and clinical studies have confirmed Grum and colleagues findings (58). Implicit in these studies is the assumption that increases in tissue and venous PCO2 correlate closely with worsening degrees of tissue dysoxia. Conversely, it is possible that such increases in PCO2 may be the result of blood flow stagnation and the accumulation in tissue of "aerobic" CO2. Schlichtig and Bowles (10) attempted to separate the individual contribution of aerobic and anaerobic CO2 production to portal venous PCO2 and intestinal mucosal PCO2 in a canine model of bowel ischemia. They noted that increases in venous PCO2 were produced initially by oxidative phosphorylation in portions of the intestine perfused at very low flow, but once intestinal mucosal O2 decreased below a critical value, increases in tissue and venous PCO2 were the result of anaerobic CO2 production. This hypothesis has been challenged by the studies of Vallet and colleagues (11), Neviere and colleagues (13), and Dubin and colleagues (14).

The results of the CO2 exchange model presented here approximate closely the experimental data of Vallet and colleagues (11), lending support to the notion that increases in tissue and venous blood PCO2 are related mainly to decreases in blood flow, not to tissue dysoxia.

Critique of the Model
The mathematic model presented here is a relatively simple description of complex and heterogeneous conditions that regulate blood–tissue CO2 interchange. As such, it deserves careful scrutiny regarding its assumptions and applicability.

The assumption of perfect mixing for the tissue and blood compartment ignores the heterogeneous nature of CO2 transport from mitochondria to red blood cell. CO2 concentration gradients are likely to exist within regions of tissue and blood, information that could be deduced by more complex morphometric models of CO2 transport. This type of detailed analysis, one that would provide the basis for evaluating individual components of this complex transport process, is beyond the scope of this model. The purpose of this analysis was to develop relatively simple relationships to elucidate the mechanisms resulting in the differences noted in the HH and IH experiments. As such, a detailed description of the various components of the CO2 transport process would have added little to the information derived from a much simpler model.

By considering blood as a homogeneous compartment, the model ignores the partitioning effect of red blood cells and of carbonic anhydrase on reaction velocity and vascular CO2 concentration. This assumption is justified by the steady-state nature of the model, in which all chemical and diffusive processes are assumed to have reached equilibrium. Thus, the model is not applicable to rapidly varying conditions in which time-dependent changes in CO2 are paramount. The time-independent nature of the model also justifies the assumption of nonpulsatile, constant blood flow.

The assumption that CO2 production occurs exclusively in the tissue compartment presumes the negligible movement of H+ from cytosol to blood. This not a realistic assumption, as during dysoxic conditions, H+ will migrate from tissue to blood bound to lactate, where it may dissociate and bind to bicarbonate to produce CO2. As a first-order approximation, however, this is not an unreasonable assumption given the difficulties in establishing the rate of CO2 formation from lactate-bound H+.

The two-compartment, lumped-parameter model analysis has been used by others to describe tissue O2 exchange (20, 21) and appears well suited as a first-degree approximation of steady-state tissue CO2 transport. A more detailed, time-dependent, multicompartment model would have been very difficult to formulate and its results suspect because many of the input parameters for a model of such complexity are poorly defined under conditions of extreme O2 supply deprivation. On the other hand, this model has a distinct advantage of having few parameters to describe tissue CO2 transport. Among these parameters are , the tissue blood flow; FCO2, the term relating the turnover rate of anaerobic ATP to CO2 production; and Kv, the mass transfer coefficient for CO2.

Increases in [CO2]v Occur Mainly during IH
A cursory inspection of Equation 5B reveals that blood flow is the primary determinant of [CO2]v. According to this equation, [CO2]v increases inversely as a function of , even under conditions of constant CO2. On the other hand, decreases in O2 produced by lowering SaO2 or hemoglobin, will influence [CO2]v only to the degree that these dysoxic conditions affect CO2. These contrasting effects can be better appreciated by transforming Equation 5B as follows,

or

During IH, [O2]a remains constant and decreases in flow are accompanied by increases in ERO2. Under these conditions, [CO2]v increases solely as a function of ERO2 to a possible maximum value of [CO2]a + [O2]a when both ERO2 and respiratory quotient equal 1.0. On the other hand, during HH flow remains constant, and increases in ERO2 result from decreases in [O2]a. Consequently, [CO2]v may increase, remain constant, or even decrease depending on the product ERO2 · [O2]a.

The Behavior of CO2 during Dysoxia
An intriguing result of the simulations is the predicted low rate of CO2 production by dysoxic tissues below O2crit. The assumption that increases in tissue and venous PCO2 relate directly to the degree of tissue dysoxia derives from our experience with exercise physiology. When working muscles approach the limits of O2 delivery, aerobic ATP production is supplemented by anaerobic metabolism, resulting in excess CO2 production. The onset of anaerobic metabolism during exercise occurs when CO2 surpasses O2 and the respiratory exchange ratio exceeds 1.0.

Under conditions of O2 supply deprivation, however, CO2 appears to be a fraction of the potential anaerobic CO2 production capacity. Vallet and colleagues (11) noted that CO2 decreased once O2 declined below O2crit (Figure 5). To fit these data, FCO2, the fraction of the anaerobic ATP turnover rate converted to CO2 was set at only 0.03. This low value for FCO2 suggests either a low rate of H+ buffering by tissue bicarbonate or a rate of anaerobic ATP production that falls short of the developing O2 debt requirements.

It may be possible, however, to estimate the fraction of the O2 debt paid by anaerobic sources of energy by considering that in the intestines approximately half of all H+ resulting from the hydrolysis of anaerobically produced ATP binds to bicarbonate to produce CO2 (3). This percentage may be even lower in skeletal muscle, given that the creatine kinase reaction also participates in the anaerobic production of ATP while consuming H+. Assuming a 50% conversion of anaerobic ATP into CO2, an FCO2 of 0.03 corresponds to an anaerobic ATP production equal to 6% of the potential O2 debt.

The Effect of Tissue Diffusion on [CO2]t
The mass transfer coefficient Kv has a pivotal influence in determining [CO2]t. This parameter is related to the pressure driven CO2 diffusion gradient and to the efficiency of the microcirculation in removing CO2 from the tissues. Decreases in Kv may correspond to microvascular alterations that impede the movement of CO2 from the tissues into the vascular space. These impediments to CO2 diffusion may be present in sepsis and in other pathologic states involving the microvasculature (26).

As shown by Figure 8, decreases in Kv result in increased tissue CO2 concentration but have no effect on vascular CO2 content. Therefore, increases in [CO2]t produced by alterations in Kv will go unnoticed by measures of venous PCO2, although they may be detected by methods that measure tissue PCO2, such as gastric tonometry or sublingual capnometry. Another useful insight provided by Figure 8 is that tissues with low Kv may experience elevations in [CO2]t under fully aerobic conditions, the result of steep tissue–blood CO2 concentration gradients.


    Conclusions
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 
According to the foregoing analysis, clinical interpretation of the arteriovenous PCO2 gradient and tissue PCO2 concentration should be done with caution and always in the context of the clinical condition resulting in altered O2 supply. The model of tissue CO2 exchange described here corroborates the findings of Vallet and colleagues (11) and others (13, 14) in that venous and tissue CO2 increases during IH but not during HH. These results support the hypothesis that increases in tissue CO2 and in the arteriovenous PCO2 gradient reflect only microcirculatory stagnation, not tissue dysoxia. Thus, from the theoretical perspective provided by the model, increases in tissue and venous PCO2 are insensitive markers of tissue dysoxia and merely reflect vascular hypoperfusion.

Moreover, an increase in tissue CO2 also appears to be a nonspecific marker of tissue dysoxia, as the potential exists for [CO2]t to rise under normoxic metabolic conditions, as the result of decreased tissue diffusivity of CO2. As such, this rise in [CO2]t represents a false-positive measure of tissue dysoxia, although it could well portend the initial stages of microvascular derangement, such as those seen in sepsis and in other pathologic conditions that may affect the diffusion of CO2 in tissue (22).


    APPENDIX
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 
Mathematical Development of the Two-compartment CO2 Exchange Model
Two compartment model equations.
The rate of change of [CO2] in the tissue compartment shown in Figure 1 is a function of CO2 and of the mass transfer of CO2 between tissue and vascular compartments. This relationship may be described as follows:

(1A)
where [CO2] represents the total CO2 concentration (dissolved and bound), the subscripts t and v denote the tissue and vascular compartments, respectively, and Kv is the mass transfer coefficient for CO2.

For the vascular compartment, the rate of change of [CO2]v depends on blood flow per unit volume of tissue (), the arteriovenous content difference, and the rate of CO2 transfer between the two compartments.


(1B)
The solution of this system of first-order differential equations is achieved by first obtaining their Laplace transforms

(2A)

(2B)
Where the terms t, v, and a denote the transformed variables. The initial [CO2] values for the tissue and vascular compartment, respectively, are [CO2]t(0) and [CO2]v(0). Solving these equations for [CO2]v(S) and [CO2]t(S) yields the following:

(3A)

(3B)
To determine the steady-state solution of the above equations, we apply the Final-Value Theorem:

Multiplying the terms of Equations 3A and 3B by S and letting S -> 0:

(4A)

(4B)
Solving this algebraic system for [CO2]t and [CO2]v yields the steady-state solutions to Equations 1A and 1B describing changes in CO2 concentration in the tissue and vascular compartments:

(5A)

(5B)

Input Functions
The input functions of the model are those that determine changes in O2, O2, and the production of CO2 by the tissues. Equations 5A and 5B were tested under conditions of progressive decreases in O2 in which the onset of anaerobic metabolism occurs according to the experimental pattern described by Cain (16). According to this nonlinear paradigm, O2 in resting animal preparations remains constant at basal value, O2basal, for O2 > a critical value of O2 (O2crit). For O2 < O2crit, O2 declines as a nonlinear function of O2.

The model employs the critical O2 extraction ratio (ERO2crit), defined as ERO2crit = O2basal/O2crit, as the means to identify O2crit. Denoting ERO2crit as an input parameter, instead of using a predetermined O2crit, enhances the flexibility of the model for a wide range of O2basal and initial O2 values, provided that the condition (O2basal/O2initial) less than ERO2crit is met.

The model computes values for O2 above or below ERO2crit as follows:

(6A)

(6B)

Implicit in Equation 6B is a progressive rise in ERO2 as O2 approaches zero (23). This lends further realism to the model by allowing additional increases in ERO2 in the region where O2 is less than O2crit.

Modeling Decreases in O2
For these simulations, the model input variable O2 is decreased sequentially from O2initial in decrements of 0.02 ml/kg/minute. For IH, the arterial SO2 is maintained constant and blood flow per unit volume of tissue is calculated as a function of O2 as

(7)
where SaO2 is the oxyhemoglobin saturation of arterial blood.

HH is simulated by maintaining blood flow constant at the initial value used for the IH simulations ( = 50 ml/min/kg). SaO2 is calculated as a function of O2 as

(8)

During the simulations, arterial PCO2 and pH are held constant at the initial values of 34 and 7.35 mm Hg, respectively (Table 1). These values correspond to a [CO2]a of 41.5 ml/dl. Venous pH is allowed to change according to the following expression:

(9)

Determination of CO2
There are two components to tissue CO2 production: CO2 produced in the mitochondria's tricarboxylic acid cycle as a result of oxidative phosphorylation (aerobic CO2) and CO2 resulting from bicarbonate buffering of hydrogen ions produced by anaerobic sources of energy (anaerobic CO2). Total CO2 production is the sum of these two.


(10)

Computation of the Aerobic CO2 Component
The relationship between O2 and aerobic CO2 is defined by the cellular respiratory quotient,

(11)
Respiratory quotient depends on the type of substrate consumed, that is, glucose, free fatty acids, or a combination thereof. For O2 > O2crit

(12)

Computation of the Anaerobic CO2 Component
In the region where O2 is less than O2crit, O2 is a nonlinear function of O2 (Equation 6B), and aerobic ATP production no longer satisfies basal energy requirements. Now the tissues must incur an O2 debt to maintain the required energy flux. The model defines the O2 debt below O2crit as

(13)

Under these conditions of O2 scarcity, the rate of cellular ATP production is the sum of mitochondrial and anaerobic ATP production. The latter is derived from glycolysis, the creatine kinase, and the adenylate kinase reactions:

(14)
Under aerobic conditions, hydrogen ions derived from the hydrolysis of ATP are recycled during oxidative phosphorylation in the mitochondria. During dysoxia, however, the hydrolysis of (ATP)anaerobic results in the generation of H+ that accumulates in the cytosol and is buffered by phosphate or bound to the histadine residues of proteins (24, 25). H+ leaving the cell is weakly bound to lactate or buffered by bicarbonate in the interstitial fluid to produce CO2 (26).

It is nearly impossible to define a function to describe accurately the rate of CO2 formation from anaerobically derived H+. For the purposes of this model, an approximation to this function may be obtained by first calculating the maximal d(ATP)anaerobic/dt, defined as the rate of anaerobic ATP production needed to fulfill the O2 debt. An expression for maximal d(ATP)anaerobic /dt may be developed by noting that each molecule of O2 consumed during aerobic phosphorylation produces six ATP molecules (27). This relationship implies a switch by the tissues from free fatty acid to glucose consumption, a metabolic strategy resulting in a more efficient use of scarce O2 molecules (28).


(15)

Introducing the term FCO2, a user-defined variable that relates anaerobic CO2 to the rate of maximal anaerobic ATP production

(16)

It should be noted that (CO2)anaerobic = 0 when O2 is more than O2crit, as according to Equation 6A O2 = O2basal in this region.

Determination of Venous Blood PO2 and PCO2
The concentration of O2 in the vascular compartment is calculated from Fick's equation as

(17)
The oxyhemoglobin saturation (SO2) is calculated from [O2]v by neglecting the contribution of dissolved O2 as

(18)
where [Hb] is the blood hemoglobin concentration in g/L.

The value for PO2 corresponding to a given SO2 at pH = 7.40 and PCO2 = 40 mm Hg is calculated from the following relationship describing the oxyhemoglobin dissociation curve (29):

(19)
Correcting for pH and PCO2

(20)

Blood PCO2 is calculated on the basis of the Henderson-Hasselbach equation (30):

(21)

Where the CO2 content of plasma, [CO2]plasma, is defined by Douglas (31) as

(22)


    FOOTNOTES
 
This article has an online supplement, which is accessible from this issue's table of contents online at www.atsjournals.org

Conflict of Interest Statement: G.G. has no declared conflict of interest.

Received in original form May 27, 2003; accepted in final form November 22, 2003


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 Conclusions
 APPENDIX
 REFERENCES
 

  1. Robin ED. Special report: dysoxia: abnormal tissue oxygen utilization. Arch Intern Med 1977;137:905–910.[Abstract]
  2. Connett RJ, Honig CR, Gayeski TE, Brooks GA. Defining hypoxia: a systems view of O2, glycolysis, energetics and intracellular PO2. J Appl Physiol 1990;68:833–842.[Abstract/Free Full Text]
  3. Raza O, Schlichtig R. Metabolic component of intestinal PCO2 during dysoxia. J Appl Physiol 2000;89:2422–2429.[Abstract/Free Full Text]
  4. Grundler W, Weil MH, Rackow EC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation 1986;74:1071–1074.[Abstract/Free Full Text]
  5. Taylor DE, Gutierrez G. Tonometry: a review of clinical studies. Crit Care Clin 1996;12:1007–1018.[CrossRef][Medline]
  6. Marik PE, Bankov A. Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med 2003;31:818–822.[CrossRef][Medline]
  7. Van der Linden P, Rausin I, Deltell A, Bekrar Y, Gilbart E, Bakker J, Vincent JL. Detection of tissue hypoxia by arteriovenous gradient for PCO2 and pH in anesthetized dogs during progressive hemorrhage. Anesth Analg 1995;80:269–275.[Abstract]
  8. Doglio GR, Pusajo JF, Egurrola MA, Bonfigli GC, Parra C, Vetere L, Bonfigli GC, Parra C, Vetere L, Hernandez MS, et al. Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991;19:1037–1040.[Medline]
  9. Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, Dubin A, Schiavi E, Jorge M, Pusajo J, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992;339:195–199.[Medline]
  10. Schlichtig R, Bowles SA. Distinguishing between aerobic and anaerobic appearance of dissolved CO2 in intestine during low flow. J Appl Physiol 1994;76:2443–2451.[Abstract/Free Full Text]
  11. Vallet B, Teboul JL, Cain S, Curtis S. Venoarterial CO2 difference during regional ischemic or hypoxic hypoxia. J Appl Physiol 2000;89:1317–1321.[Abstract/Free Full Text]
  12. Gutierrez G, Pohil RJ, Andry JM, Strong R, Narayana P. Bioenergetics of rabbit skeletal muscle during hypoxemia and ischemia. J Appl Physiol 1988;65:608–616.[Abstract/Free Full Text]
  13. Neviere R, Chagnon JL, Teboul JL, Vallet B, Wattel FB. Small intestine intramucosal PCO2 and microvascular blood during hypoxic and ischemic hypoxia. Crit Care Med 2002;30:379–384.[CrossRef][Medline]
  14. Dubin A, Murias G, Estenssoro E, Canales H, Badie J, Pozo M, Sottile JP, Baran M, Palizas F, Laporte M. Intramucosal-arterial PCO2 gap fails to reflect intestinal dysoxia in hypoxic hypoxia. Crit Care 2002;6:514–520.[CrossRef][Medline]
  15. Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000;80:681–715.[Abstract/Free Full Text]
  16. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol 1977;42:228–234.[Abstract/Free Full Text]
  17. Weil MH, Rackow EC, Trevino R, Grundler W, Falk J, Grifel M. Difference in acid base state between venous and arterial blood during CPR. N Engl J Med 1986;315:153–156.[Abstract]
  18. Chalapathirao VG, Weil MH, Gazmuri RJ, Deshmukh HG, Bisera J, Rackow EC. Increases in coronary vein CO2 during cardiac resuscitation. J Appl Physiol 1990;68:1405–1408.[Abstract/Free Full Text]
  19. Grum CM, Fiddian-Green RG, Pittenger GL, Grant BJ, Rothman ED, Dantzker DR. Adequacy of tissue oxygenation in intact dog intestine. J Appl Physiol 1984;56:1065–1069.[Abstract/Free Full Text]
  20. Wagner P. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol 1996;58:21–50.[CrossRef][Medline]
  21. Piiper J, Scheid P. Modeling oxygen availability to exercising muscle. Respir Physiol 1999;118:95–101.[CrossRef][Medline]
  22. Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 2000;7:83–101.[CrossRef][Medline]
  23. Nelson DP, King CE, Dodd SL, Schumacker PT, Cain SM. Systemic and intestinal limits of O2 extraction in the dog. J Appl Physiol 1987;63:387–394.[Abstract/Free Full Text]
  24. Gevers W. Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol 1977;9:867–874.[Medline]
  25. Hochachka PW, Mommsen TP. Protons and anaerobiosis. Science 1983;219:1391–1397.[Abstract/Free Full Text]
  26. Gutierrez G, Wulf ME. Lactic acidosis in sepsis: a commentary. Intensive Care Med 1996;22:6–16.[CrossRef][Medline]
  27. Connett RJ, Honig CR, Gayeski TEJ, Brooks GA. Defining hypoxia: a systems view of O2, glycolysis, energetics, and intracellular PO2. J Appl Physiol 1990;68:833–842.
  28. Hochachka PW. Defense strategies against hypoxia and hypothermia. Science 1986;231:234–241.[Abstract/Free Full Text]
  29. Severinghaus JW. Simple, accurate equations for human blood O2 dissociation computations. J Appl Physiol 1979;46:599–602.[Abstract/Free Full Text]
  30. Giovannini I, Chiarla C, Boldrini G, Castagneto M. Calculation of venoarterial CO2 concentration difference. J Appl Physiol 1993;74:959–964.[Abstract/Free Full Text]
  31. Douglas AR, Jones NL, Reed JW. Calculation of whole blood CO2 content. J Appl Physiol 1988;65:473–477.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Nemery, W. W. Yew, R. Albert, C. Brun-Buisson, W. MacNee, F. J. Martinez, D. C. Angus, and E. Abraham
Tuberculosis, Nontuberculous Lung Infection, Pleural Disorders, Pulmonary Function, Respiratory Muscles, Occupational Lung Disease, Pulmonary Infections, and Social Issues in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 554 - 562.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. L. Verdant, D. De Backer, J. Creteur, J.-L. Vincent, J. A. Guzman, and J. A. Kruse
The following is the abstract of the article discussed in the subsequent letter:
J Appl Physiol, March 1, 2005; 98(3): 1149 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. A. Guzman, M. S. Dikin, and J. A. Kruse
Lingual, splanchnic, and systemic hemodynamic and carbon dioxide tension changes during endotoxic shock and resuscitation
J Appl Physiol, January 1, 2005; 98(1): 108 - 113.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200305-702OCv1
169/4/525    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutierrez, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow